Literature DB >> 9248886

Primary localized cutaneous amyloidosis: a clinicopathologic study from Saudi Arabia.

J T al-Ratrout1, M B Satti.   

Abstract

BACKGROUND: Primary localized cutaneous amyloidosis (PLCA) refers to deposition of amyloid in apparently previously normal skin with no evidence of deposits in internal organs. Certain ethnic groups are particularly predisposed. The objective of this study was to investigate the occurrence of PLCA in a hospital-based set-up and to review the clinico-pathologic findings of histologically confirmed cases.
METHODS: Methods included a retrospective evaluation of the records and paraffin sections of skin biopsies of all patients, diagnosed clinically as cutaneous amyloidosis in a tertiary care teaching hospital during the period 1987-95.
RESULTS: Twenty-one out of 42 suspected cases were histologically confirmed as PLCA; the total number of biopsied patients during the whole period was 920. Eleven were cases of lichen amyloidosis (LA) and 10 were of macular amyloidosis (MA). All were adults, and women dominated in MA. The mean duration of symptoms was shorter for the latter subtype. Histologically epidermal changes were the main differentiating feature between LA and MA.
CONCLUSIONS: PLCA is a rare chronic progressive skin disorder affecting adults, with a prevalence of 0.15 among patients attending the dermatology clinic in a tertiary care teaching hospital in Saudi Arabia. There were few differences in demographic profile or histochemical characteristics between LA and MA. Meticulous histologic examination of sections and even sequential biopsies may be needed to confirm the diagnosis in clinically suspected cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248886     DOI: 10.1046/j.1365-4362.1997.00109.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

Review 1.  New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Authors:  Iuliana Vaxman; Angela Dispenzieri; Eli Muchtar; Morie Gertz
Journal:  Blood Rev       Date:  2019-11-02       Impact factor: 8.250

2.  Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study.

Authors:  Krati Mehrotra; Rupali Dewan; Jagannath V Kumar; Abhinav Dewan
Journal:  J Clin Diagn Res       Date:  2017-08-01

3.  Macular Amyloidosis and Epstein-Barr Virus.

Authors:  Yalda Nahidi; Naser Tayyebi Meibodi; Zahra Meshkat; Narges Nazeri
Journal:  Dermatol Res Pract       Date:  2016-02-14

4.  Clinicopathological Study of Primary Cutaneous Amyloidosis in a Tertiary Care Center of Eastern India Reveals Insignificant Association with Friction, Scrubbing, and Photo-Exposure: How valid is the "Keratinocyte Hypothesis"?

Authors:  Projna Biswas; Dayamay Pal; Abhishek De; Gobinda Chatterjee; Arghyaprasun Ghosh; Sudip Das; Pijush Kanti Das; Aarti Sarda; Sumit Sen
Journal:  Indian J Dermatol       Date:  2019 Jan-Feb       Impact factor: 1.494

5.  A clinico-epidemiological study of macular amyloidosis from north India.

Authors:  Anshu Bandhlish; Asok Aggarwal; Ravinder V Koranne
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.